BR0008536A - Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro - Google Patents
Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitroInfo
- Publication number
- BR0008536A BR0008536A BR0008536-7A BR0008536A BR0008536A BR 0008536 A BR0008536 A BR 0008536A BR 0008536 A BR0008536 A BR 0008536A BR 0008536 A BR0008536 A BR 0008536A
- Authority
- BR
- Brazil
- Prior art keywords
- mas
- additives
- vitro fertilization
- additive
- culture medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"USOS DE UM MEIO DE CULTURA, E DE PELO MENOS UM MAS, ANáLOGO DE MAS OU UM ADITIVO OU ADITIVOS,E, PROCESSO PARA FERTILIZAçãO IN VITRO". A presente invenção refere-se ao uso de novo princípio para aumentar a viabilidade e o potencial de gravidez de oócitos e pré-embriões obtidos em conexão com fertilização in vitro e tratamento de transferência de pré-embrião. Mais especificamente, a melhora através de elevação do conteúdo de Esteróis de Ativação da Meiose (MAS) no meio em que a fertilização in vitro acontece. Isto é alcançado através de exposição e cultivo de um ou mais oócitos com espermatozóides no meio de cultura compreendendo pelo menos um esterol de ativação da meiose (MAS), um análogo de MAS, e/ou aditivo ou aditivos capazes de estimulação endógena da acumulação de pelo menos um MAS. Aditivos preferidos são FSH e EGF.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900273 | 1999-02-26 | ||
PCT/DK2000/000080 WO2000052142A2 (en) | 1999-02-26 | 2000-02-25 | Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008536A true BR0008536A (pt) | 2001-11-06 |
Family
ID=8091693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008536-7A BR0008536A (pt) | 1999-02-26 | 2000-02-25 | Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro |
Country Status (16)
Country | Link |
---|---|
US (2) | US20020042927A1 (pt) |
EP (1) | EP1157096A2 (pt) |
JP (1) | JP2002537801A (pt) |
KR (1) | KR20020013505A (pt) |
CN (1) | CN1341147A (pt) |
AU (1) | AU2659200A (pt) |
BR (1) | BR0008536A (pt) |
CA (1) | CA2365225A1 (pt) |
CZ (1) | CZ20012671A3 (pt) |
HU (1) | HUP0200201A3 (pt) |
IL (1) | IL144529A0 (pt) |
MX (1) | MXPA01008657A (pt) |
NO (1) | NO20014120L (pt) |
PL (1) | PL350222A1 (pt) |
WO (1) | WO2000052142A2 (pt) |
ZA (1) | ZA200106101B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE306942T1 (de) * | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
US20030153808A1 (en) * | 2000-02-25 | 2003-08-14 | Christa Hegele-Hartung | Implantation rate using ff-mas |
AU3376501A (en) * | 2000-02-25 | 2001-09-03 | Novo Nordisk A/S | Improvement of implantation rate |
WO2001088098A2 (en) * | 2000-05-18 | 2001-11-22 | Schering Aktiengesellschaft | Fertilization of aged oocytes |
EP1216701A1 (en) * | 2000-12-22 | 2002-06-26 | Schering Aktiengesellschaft | Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process |
EP1245572A1 (en) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
CL2008003692A1 (es) * | 2008-12-11 | 2011-05-13 | Univ Pontificia Catolica Chile | Fraccion de hormona foliculo estimulante (fsh) con un punto isoelectrico basico mayor a 4 y cadena de carbohidratos altamente ramificados y/o bisectadas; metodo de purificacion de dicha fraccion; composicion que comprende la fraccion |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563059A (en) * | 1993-02-23 | 1996-10-08 | Genentech, Inc. | Use of human inhibin and human activin to increase the number of mature primate oocytes |
US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
HUP9800731A3 (en) * | 1995-03-06 | 2000-03-28 | Novo Nordisk As | Stimulation of meiosis |
EP1156822B1 (en) * | 1999-02-24 | 2006-02-08 | Novo Nordisk A/S | Iin vitro method for synchronisation of oocyte maturation |
ATE361091T1 (de) * | 1999-02-24 | 2007-05-15 | Novo Nordisk As | Behandlung von unfruchtbarkeit |
ATE306942T1 (de) * | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
US6544166B1 (en) * | 1999-11-25 | 2003-04-08 | Groendahl Christian | Treatment of human infertility |
-
2000
- 2000-02-25 EP EP00904869A patent/EP1157096A2/en not_active Withdrawn
- 2000-02-25 PL PL00350222A patent/PL350222A1/xx not_active Application Discontinuation
- 2000-02-25 CN CN00804261A patent/CN1341147A/zh active Pending
- 2000-02-25 HU HU0200201A patent/HUP0200201A3/hu unknown
- 2000-02-25 WO PCT/DK2000/000080 patent/WO2000052142A2/en not_active Application Discontinuation
- 2000-02-25 KR KR1020017010969A patent/KR20020013505A/ko not_active Application Discontinuation
- 2000-02-25 AU AU26592/00A patent/AU2659200A/en not_active Abandoned
- 2000-02-25 MX MXPA01008657A patent/MXPA01008657A/es unknown
- 2000-02-25 CZ CZ20012671A patent/CZ20012671A3/cs unknown
- 2000-02-25 BR BR0008536-7A patent/BR0008536A/pt not_active IP Right Cessation
- 2000-02-25 JP JP2000602754A patent/JP2002537801A/ja active Pending
- 2000-02-25 IL IL14452900A patent/IL144529A0/xx unknown
- 2000-02-25 CA CA002365225A patent/CA2365225A1/en not_active Abandoned
-
2001
- 2001-07-25 ZA ZA200106101A patent/ZA200106101B/en unknown
- 2001-08-14 US US09/929,800 patent/US20020042927A1/en not_active Abandoned
- 2001-08-24 NO NO20014120A patent/NO20014120L/no not_active Application Discontinuation
-
2003
- 2003-07-24 US US10/626,053 patent/US20050175976A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20014120L (no) | 2001-10-25 |
WO2000052142A3 (en) | 2001-03-22 |
JP2002537801A (ja) | 2002-11-12 |
HUP0200201A3 (en) | 2002-06-28 |
CZ20012671A3 (cs) | 2002-01-16 |
ZA200106101B (en) | 2002-02-04 |
PL350222A1 (en) | 2002-11-18 |
EP1157096A2 (en) | 2001-11-28 |
AU2659200A (en) | 2000-09-21 |
US20020042927A1 (en) | 2002-04-11 |
KR20020013505A (ko) | 2002-02-20 |
IL144529A0 (en) | 2002-05-23 |
CN1341147A (zh) | 2002-03-20 |
CA2365225A1 (en) | 2000-09-08 |
MXPA01008657A (es) | 2003-06-24 |
WO2000052142A2 (en) | 2000-09-08 |
NO20014120D0 (no) | 2001-08-24 |
HUP0200201A2 (hu) | 2002-05-29 |
US20050175976A1 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508074A (pt) | Composto e processo de regulagem de meiose em uma célula- embrião de mamífero | |
BR0202278A (pt) | Dispositivos e processos para a colheita de células | |
DK0686192T3 (da) | In vitro fremgangsmåde til at forøge fertilitet under tilstedeværelse inhibin/activinkombinationer | |
HUP0500477A2 (hu) | Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával | |
DE69329240D1 (de) | 17-ether und thioether von 4-aza-steroiden | |
PT716689E (pt) | Processo para a preparacao e cultura de celulas progenitoras hematopoieticas | |
ES2167326T3 (es) | N-acetilglucosaminil-transferasa, gen que la codifica, vectores y huespedes transformados correspondientes y procedimientos para su produccion. | |
HUP9904616A2 (hu) | Meiózist befolyásoló holesztánszármazékok | |
BR0008536A (pt) | Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro | |
DK0701604T3 (da) | Immortalisering af dendritiske celler med V-myc-onkogenet | |
ES2131972T3 (es) | Derivados de sulfamato de derivados del 1,3,5(10)-estratrieno, procedimiento para su fabricacion y composiciones farmaceuticas que contienen estos compuestos. | |
BR9913534A (pt) | Processo para gerar plantas haplóides duplicadas | |
DK282784D0 (da) | 1-alkyl-androsta-1,4-dien-3,17-dioner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem | |
BR9801085A (pt) | Processo para a preparação de moenomicina a. | |
ATE342062T1 (de) | Angiotensin ii zur verbesserung der befruchtung | |
DE69333547D1 (de) | Therapeutische anwendungen von chimänischer organogenese | |
NO20003880D0 (no) | Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser | |
BR0114113A (pt) | Ativador para um fermento à base de bactérias lácteas, utilização do mesmo, fermento ativado à base de bactérias lácteas, e, processo para a preparação de um produto lácteo | |
ATE299178T1 (de) | Verfahren zur herstellung von säugetier-zellinien | |
ES2163001T3 (es) | Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica. | |
Alexandre et al. | Time‐lapse cinematography study of the germinal vesicle behaviour in mouse primary oocytes treated with activators of protein kinases A and C | |
AU1692901A (en) | Treatment of human infertility | |
BR0109482A (pt) | Oscilogenina de fator de esperma | |
AR003967A1 (es) | Epimeros de (22r)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa- androst-1-eno-17beta-carboxamida, un proceso para su preparacion y unacomposicion farmaceutica que los comprenden. | |
Coughlan | 'From the moment of conception...': the Vatican instruction on artificial procreation techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |